Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

In Vitro Generation of Heart Field-specific Cardiac Progenitor Cells.

Tampakakis E, Miyamoto M, Kwon C.

J Vis Exp. 2019 Jul 3;(149). doi: 10.3791/59826.

PMID:
31329174
2.

Precardiac organoids form two heart fields via Bmp/Wnt signaling.

Andersen P, Tampakakis E, Jimenez DV, Kannan S, Miyamoto M, Shin HK, Saberi A, Murphy S, Sulistio E, Chelko SP, Kwon C.

Nat Commun. 2018 Aug 7;9(1):3140. doi: 10.1038/s41467-018-05604-8.

3.

Pulmonary Effective Arterial Elastance as a Measure of Right Ventricular Afterload and Its Prognostic Value in Pulmonary Hypertension Due to Left Heart Disease.

Tampakakis E, Shah SJ, Borlaug BA, Leary PJ, Patel HH, Miller WL, Kelemen BW, Houston BA, Kolb TM, Damico R, Mathai SC, Kasper EK, Hassoun PM, Kass DA, Tedford RJ.

Circ Heart Fail. 2018 Apr;11(4):e004436. doi: 10.1161/CIRCHEARTFAILURE.117.004436.

4.

In search of markers of pulmonary vascular remodelling in pulmonary hypertension due to left heart disease.

Tampakakis E.

Eur J Heart Fail. 2018 Apr;20(4):735-737. doi: 10.1002/ejhf.1137. Epub 2018 Jan 15. No abstract available.

5.

Use of a neonatal rat system as a bioincubator to generate adult-like mature cardiomyocytes from human and mouse pluripotent stem cells.

Cho GS, Tampakakis E, Andersen P, Kwon C.

Nat Protoc. 2017 Oct;12(10):2097-2109. doi: 10.1038/nprot.2017.089. Epub 2017 Sep 7.

6.

Neonatal Transplantation Confers Maturation of PSC-Derived Cardiomyocytes Conducive to Modeling Cardiomyopathy.

Cho GS, Lee DI, Tampakakis E, Murphy S, Andersen P, Uosaki H, Chelko S, Chakir K, Hong I, Seo K, Chen HV, Chen X, Basso C, Houser SR, Tomaselli GF, O'Rourke B, Judge DP, Kass DA, Kwon C.

Cell Rep. 2017 Jan 10;18(2):571-582. doi: 10.1016/j.celrep.2016.12.040.

7.

Balancing the positives and negatives of the diastolic pulmonary gradient.

Tampakakis E, Tedford RJ.

Eur J Heart Fail. 2017 Jan;19(1):98-100. doi: 10.1002/ejhf.704. No abstract available.

8.

Pulmonary Arterial Compliance in Acute Respiratory Distress Syndrome: Clinical Determinants and Association With Outcome From the Fluid and Catheter Treatment Trial Cohort.

Metkus TS, Tampakakis E, Mullin CJ, Houston BA, Kolb TM, Mathai SC, Damico R, Maron BA, Hassoun PM, Brower RG, Tedford RJ.

Crit Care Med. 2017 Mar;45(3):422-429. doi: 10.1097/CCM.0000000000002186.

9.

Heart Rate Dependence of the Pulmonary Resistance x Compliance (RC) Time and Impact on Right Ventricular Load.

Metkus TS, Mullin CJ, Grandin EW, Rame JE, Tampakakis E, Hsu S, Kolb TM, Damico R, Hassoun PM, Kass DA, Mathai SC, Tedford RJ.

PLoS One. 2016 Nov 18;11(11):e0166463. doi: 10.1371/journal.pone.0166463. eCollection 2016.

10.

Functional Coupling with Cardiac Muscle Promotes Maturation of hPSC-Derived Sympathetic Neurons.

Oh Y, Cho GS, Li Z, Hong I, Zhu R, Kim MJ, Kim YJ, Tampakakis E, Tung L, Huganir R, Dong X, Kwon C, Lee G.

Cell Stem Cell. 2016 Jul 7;19(1):95-106. doi: 10.1016/j.stem.2016.05.002. Epub 2016 Jun 16.

11.

Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension.

Hsu S, Houston BA, Tampakakis E, Bacher AC, Rhodes PS, Mathai SC, Damico RL, Kolb TM, Hummers LK, Shah AA, McMahan Z, Corona-Villalobos CP, Zimmerman SL, Wigley FM, Hassoun PM, Kass DA, Tedford RJ.

Circulation. 2016 Jun 14;133(24):2413-22. doi: 10.1161/CIRCULATIONAHA.116.022082. Epub 2016 May 11.

12.

Intravenous Lipid Infusion Induces Endoplasmic Reticulum Stress in Endothelial Cells and Blood Mononuclear Cells of Healthy Adults.

Tampakakis E, Tabit CE, Holbrook M, Linder EA, Berk BD, Frame AA, Bretón-Romero R, Fetterman JL, Gokce N, Vita JA, Hamburg NM.

J Am Heart Assoc. 2016 Jan 11;5(1). pii: e002574. doi: 10.1161/JAHA.115.002574.

13.

Reply: characterization of pulmonary hypertension in heart failure using the diastolic pressure gradient: the conundrum of high and low diastolic pulmonary gradient.

Tampakakis E, Tedford RJ.

JACC Heart Fail. 2015 May;3(5):426-427. doi: 10.1016/j.jchf.2015.02.002. No abstract available.

14.

The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease.

Tampakakis E, Leary PJ, Selby VN, De Marco T, Cappola TP, Felker GM, Russell SD, Kasper EK, Tedford RJ.

JACC Heart Fail. 2015 Jan;3(1):9-16. doi: 10.1016/j.jchf.2014.07.010. Epub 2014 Nov 12.

15.

The effect of cumulative length of hospital stay on the antifungal resistance of Candida strains isolated from critically ill surgical patients.

Kourkoumpetis TK, Velmahos GC, Ziakas PD, Tampakakis E, Manolakaki D, Coleman JJ, Mylonakis E.

Mycopathologia. 2011 Feb;171(2):85-91. doi: 10.1007/s11046-010-9369-3. Epub 2010 Oct 8.

16.

Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay.

Okoli I, Coleman JJ, Tampakakis E, An WF, Holson E, Wagner F, Conery AL, Larkins-Ford J, Wu G, Stern A, Ausubel FM, Mylonakis E.

PLoS One. 2009 Sep 14;4(9):e7025. doi: 10.1371/journal.pone.0007025. Erratum in: PLoS One. 2010;5(4) doi:10.1371/annotation/76699885-a47e-426c-accd-35576696c4f2.. Tempakakis, Emmanouil [corrected to Tampakakis, Emmanouil].

17.

Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model.

Pukkila-Worley R, Peleg AY, Tampakakis E, Mylonakis E.

Eukaryot Cell. 2009 Nov;8(11):1750-8. doi: 10.1128/EC.00163-09. Epub 2009 Aug 7.

18.

Interaction of Candida albicans with an intestinal pathogen, Salmonella enterica serovar Typhimurium.

Tampakakis E, Peleg AY, Mylonakis E.

Eukaryot Cell. 2009 May;8(5):732-7. doi: 10.1128/EC.00016-09. Epub 2009 Mar 27.

19.

Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36.

Means TK, Mylonakis E, Tampakakis E, Colvin RA, Seung E, Puckett L, Tai MF, Stewart CR, Pukkila-Worley R, Hickman SE, Moore KJ, Calderwood SB, Hacohen N, Luster AD, El Khoury J.

J Exp Med. 2009 Mar 16;206(3):637-53. doi: 10.1084/jem.20082109. Epub 2009 Feb 23.

20.

A C. elegans-based, whole animal, in vivo screen for the identification of antifungal compounds.

Tampakakis E, Okoli I, Mylonakis E.

Nat Protoc. 2008;3(12):1925-31. doi: 10.1038/nprot.2008.193.

PMID:
19180076
21.

Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans.

Peleg AY, Tampakakis E, Fuchs BB, Eliopoulos GM, Moellering RC Jr, Mylonakis E.

Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14585-90. doi: 10.1073/pnas.0805048105. Epub 2008 Sep 15.

Supplemental Content

Loading ...
Support Center